Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 550 of 2529 entries
View as:

Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00820222 Org: User:
Start: 04/14/09 End: 03/22/18 Due: 03/22/19

Optimal Titration Regimen for SBR759 in Lowering Serum Phosphate Levels in Asian Chronic Kidney Disease Patients on Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT00704678 Org: User:
Start: 08/31/08 End: - Due: -

Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT02422615 Org: User:
Start: 06/09/15 End: 01/11/23 Due: 01/11/24

A Global Imatinib and Nilotinib Pregnancy Exposure Registry

Phase: N/A Priority: Normal
NCT ID: NCT01289054 Org: User:
Start: 01/31/11 End: 03/31/15 Due: 03/31/16

Assessment of Switching From Salmeterol/Fluticasone to Indacaterol/Glycopyrronium in a symtomaticCOPD Patient Cohort

Phase: N/A Priority: Normal
NCT ID: NCT02516592 Org: User:
Start: 10/13/15 End: 05/04/17 Due: 05/04/18

Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00099866 Org: User:
Start: 01/31/04 End: 08/31/05 Due: 08/31/06

A Prospective Multicenter Study for the Assessment of Treatment Patterns, Effectiveness and Safety of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis in a Real-world Setting in China

Phase: N/A Priority: Normal
NCT ID: NCT04894890 Org: User:
Start: 09/26/21 End: 12/15/23 Due: 12/15/24

A Study of Inclisiran in Participants With Homozygous Familial Hypercholesterolemia (HoFH)

Phase: N/A Priority: Normal
NCT ID: NCT03851705 Org: User:
Start: 02/06/19 End: 09/09/21 Due: 09/09/22

A Worldwide Survey on the Understanding of Psoriatic Disease Among Patients With Psoriasis and Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT04614831 Org: User:
Start: 11/12/20 End: 06/03/21 Due: 06/03/22

A Phase I Study of Oral BGJ398 in Asian Patients

Phase: N/A Priority: Normal
NCT ID: NCT01697605 Org: User:
Start: 10/19/12 End: 02/07/19 Due: 02/07/20

A Prospective Evaluation of Natriuretic Peptide Based Referral of CHF Patients in Primary Care

Phase: N/A Priority: Normal
NCT ID: NCT02807857 Org: User:
Start: 07/07/16 End: 03/23/18 Due: 03/23/19

Open Label Study of Postmenopausal Women With ER and /or PgR Positive Breast Cancer Treated With Letrozole

Phase: N/A Priority: Normal
NCT ID: NCT00237224 Org: User:
Start: 02/28/03 End: - Due: -

Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01637272 Org: User:
Start: 01/08/13 End: 08/07/15 Due: 08/07/16

Efficacy Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail

Phase: N/A Priority: Normal
NCT ID: NCT00443820 Org: User:
Start: 12/31/06 End: 06/30/08 Due: 06/30/09

Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma Treatment

Phase: N/A Priority: Normal
NCT ID: NCT03052517 Org: User:
Start: 03/21/17 End: 03/16/20 Due: 03/16/21

Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01421004 Org: User:
Start: 12/31/11 End: 07/31/14 Due: 07/31/15

A Phase I Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT02399202 Org: User:
Start: 11/06/15 End: 03/21/16 Due: 03/21/17

LDE225 for Patients With PTCH1 or SMO Mutated Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02002689 Org: User:
Start: 02/28/14 End: 03/31/15 Due: 03/31/16

Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00427583 Org: User:
Start: 05/31/06 End: - Due: -

Canakinumab in Patients With Active Hyper-IgD Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01303380 Org: User:
Start: 03/31/11 End: 07/31/14 Due: 07/31/15

Pharmacokinetic (PK) and Safety Study of Iptacopan (LNP023) in Participants With Mild, Moderate, and Severe Hepatic Impairment Compared to Matched Control Healthy Participants With Normal Hepatic Function.

Phase: N/A Priority: Normal
NCT ID: NCT05078580 Org: User:
Start: 11/10/21 End: 06/20/22 Due: 06/20/23

A Study of Multiple Sclerosis Routine Clinical Practice: Impact on Adherence and Clinical Outcomes of Ofatumumab Treated Patients

Phase: N/A Priority: Normal
NCT ID: NCT06897657 Org: User:
Start: 11/06/23 End: 07/25/24 Due: 07/25/25

Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®

Phase: N/A Priority: Normal
NCT ID: NCT00668200 Org: User:
Start: 05/31/08 End: 11/30/12 Due: 11/30/13

In Silico Study Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Patients With Established Cardiovascular Disease

Phase: N/A Priority: Normal
NCT ID: NCT05974345 Org: User:
Start: 11/03/23 End: 12/15/23 Due: 12/15/24

Clinical Study of Asciminib in Previously Treated Indian Patients With Ph+ CML-CP Without T315I Mutation and in Patients With Ph+ CML-CP With T315I Mutation

Phase: N/A Priority: Normal
NCT ID: NCT06427811 Org: User:
Start: 11/28/24 End: 11/01/26 Due: 11/01/27